Cargando…
Hepatocellular carcinoma: Understanding molecular mechanisms for defining potential clinical modalities
Liver cancer is the sixth most commonly occurring cancer and costs millions of lives per year. The diagnosis of hepatocellular carcinoma (HCC) has relied on scanning techniques and serum-based markers such as α-fetoprotein. These measures have limitations due to their detection limits and asymptomat...
Autores principales: | Natu, Abhiram, Singh, Anjali, Gupta, Sanjay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637668/ https://www.ncbi.nlm.nih.gov/pubmed/34904030 http://dx.doi.org/10.4254/wjh.v13.i11.1568 |
Ejemplares similares
-
Advanced therapeutic modalities in hepatocellular carcinoma: Novel insights
por: Shokoohian, Bahare, et al.
Publicado: (2021) -
Emerging treatment modalities for systemic therapy in hepatocellular carcinoma
por: Qing, Xin, et al.
Publicado: (2021) -
Cellular based treatment modalities for unresectable hepatocellular carcinoma
por: Damiris, Konstantinos, et al.
Publicado: (2021) -
Molecular Mechanisms Underlying Hepatocellular Carcinoma
por: Merle, Philippe, et al.
Publicado: (2009) -
In-Silico Analysis of Chromatin Modifiers and Profiling of Histone Deacetylases (HDAC's) in Human Oral Cancer
por: Sajnani, Anand K., et al.
Publicado: (2021)